{"id":90425,"date":"2020-11-24T14:56:00","date_gmt":"2020-11-24T14:56:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2768130"},"modified":"2020-11-24T14:56:00","modified_gmt":"2020-11-24T14:56:00","slug":"rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/","title":{"rendered":"RNA-Based Therapeutics and Vaccines Market Witness Robust Growth | Alnylam Pharmaceuticals,  Arbutus Biopharma,  Arrowhead Pharmaceuticals"},"content":{"rendered":"<p><strong>Global RNA-Based Therapeutics and Vaccines Market Size, Status and Forecast 2020-2026\u00a0 , Covid 19 Outbreak Impact <\/strong>research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market\u2019s historic and forecast market growth by geography. It places the market within the context of the wider RNA-Based Therapeutics and Vaccines market, and compares it with other markets., market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, RNA-Based Therapeutics and Vaccines market size forecast, market data &amp; Graphs and Statistics, Tables, Bar &amp;Pie Charts, and many more for business intelligence. <strong>Get<\/strong> <strong>complete Report (Including Full TOC, 100+ Tables &amp; Figures, and Chart). &#8211; In-depth Analysis Pre &amp; Post COVID-19 Market <\/strong><strong>Outbreak Impact Analysis &amp; <\/strong><strong>Situation by Region<\/strong><\/p>\n<p>Download Free Sample Copy of \u2018<strong>RNA-Based Therapeutics and Vaccines<\/strong> market\u2019 Report @<\/p>\n<p><a href=\"https:\/\/reportocean.com\/industry-verticals\/sample-request?report_id=QY4851&amp;cat_title=Healthcare\"><strong>https:\/\/reportocean.com\/industry-verticals\/sample-request?report_id=QY4851&amp;cat_title=Healthcare<\/strong><\/a><\/p>\n<p>The key players covered in this study<\/p>\n<p>Alnylam Pharmaceuticals<\/p>\n<p>Arbutus Biopharma<\/p>\n<p>Arrowhead Pharmaceuticals<\/p>\n<p>BioNTech<\/p>\n<p>CureVac<\/p>\n<p>Dicerna Pharmaceuticals<\/p>\n<p>Regulus Therapeutics<\/p>\n<p>Marina Biotech<\/p>\n<p>MiRagen Therapeutics<\/p>\n<p>Moderna Therapeutics<\/p>\n<p>Quark Pharmaceuticals<\/p>\n<p>Roche<\/p>\n<p>Sylentis<\/p>\n<p>Market segment by Type, the product can be split into<\/p>\n<p>RNA-Based Therapeutics<\/p>\n<p>RNA-Based Vaccines<\/p>\n<p>Market segment by Application, split into<\/p>\n<p>Oncology<\/p>\n<p>Immunology<\/p>\n<p>Ophthalmology<\/p>\n<p>Cardiovascular Diseases<\/p>\n<p>Infectious Diseases<\/p>\n<p>Genetic Diseases<\/p>\n<p>Others<\/p>\n<p><strong>A combination of factors, including COVID-19 containment situation, end-use market recovery &amp; Recovery Timeline of 2020\/ 2021<\/strong><\/p>\n<table width=\"92%\">\n<tbody>\n<tr>\n<td width=\"24%\"><strong>covid-19 scenario<\/strong><\/td>\n<td width=\"22%\"><strong>Market Behavior\/ Level of Risk and Opportunity<\/strong><\/td>\n<td width=\"20%\"><strong>End Industry Behavior\/ Opportunity Assessment<\/strong><\/td>\n<td width=\"17%\"><strong>Expected Industry Recovery Timeline<\/strong><\/td>\n<td width=\"15%\"><strong>Business Impact Horizon<\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"24%\"><strong>Opening of Economy by Q3 2020<\/strong><\/td>\n<td width=\"22%\">xx<\/td>\n<td width=\"20%\">xx<\/td>\n<td width=\"17%\">xx<\/td>\n<td width=\"15%\">xx<\/td>\n<\/tr>\n<tr>\n<td width=\"24%\"><strong>Recovery \u2013 Opening of Economy extended till Q4 2020 \/ Q1 2021<\/strong><\/td>\n<td width=\"22%\">xx<\/td>\n<td width=\"20%\">xx<\/td>\n<td width=\"17%\">xx<\/td>\n<td width=\"15%\">xx<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>\u00a0<\/strong><strong>Under COVID-19 Outbreak Impact Analysis:<\/strong><strong><br \/>\n<\/strong>We analyzed industry trends in the context of COVID-19. We analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets. We analyze the impact of COVID-19 on various regions and major countries.<br \/>\nThe impact of COVID-19 on the future development of the industry is pointed out.<\/p>\n<p><strong>Study Explore : <\/strong><\/p>\n<ul>\n<li><strong>Market Behavior\/ Level of Risk and Opportunity<\/strong><\/li>\n<li><strong>End Industry Behavior\/ Opportunity Assessment<\/strong><\/li>\n<li><strong>Expected Industry Recovery Timeline<\/strong><\/li>\n<\/ul>\n<p>For more information or any query mail at <a href=\"mailto:sales@reportocean.com\">sales@reportocean.com<\/a><\/p>\n<p><strong>Geographical Breakdown:<\/strong> The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery path of Covid 19 for all regions, key developed countries and major emerging markets.<\/p>\n<p><strong>Countries:<\/strong>\u00a0Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam<\/p>\n<p><strong>In-Depth Qualitative COVID 19 Outbreak Impact Analysis Include Identification And Investigation Of The Following Aspects:<\/strong> Market Structure, Growth Drivers, Restraints and Challenges, Emerging Product Trends &amp; Market Opportunities, Porter\u2019s Fiver Forces. The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios. The report basically gives information about the Market trends, growth factors, limitations, opportunities, challenges, future forecasts, and details about all the key market players.<\/p>\n<p><strong>(Check Our Exclusive Offer: 30% to 40% Discount)<\/strong><\/p>\n<p><strong><a href=\"https:\/\/reportocean.com\/industry-verticals\/sample-request?report_id=QY4851&amp;cat_title=Healthcare\">https:\/\/reportocean.com\/industry-verticals\/sample-request?report_id=QY4851&amp;cat_title=Healthcare<\/a><\/strong><\/p>\n<p><strong>Key questions answered:<\/strong><strong> Study Explore <\/strong><strong>COVID 19 Outbreak Impact Analysis<\/strong><\/p>\n<p><strong>The study objectives of this report are:<\/strong><\/p>\n<ul>\n<li>To study and analyze the global market size (value &amp; volume) by company, key regions\/countries, products and application, history data from 2014 to 2018, and forecast to 2025.<\/li>\n<li>To understand the structure of market by identifying its various subsegments.<\/li>\n<li>To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).<\/li>\n<li>Focuses on the key global manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.<\/li>\n<li>To analyze the growth trends, future prospects, and their contribution to the total market.<\/li>\n<li>To project the value and volume of submarkets, with respect to key regions (along with their respective key countries).<\/li>\n<li>To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.<\/li>\n<li>To strategically profile the key players and comprehensively analyze their growth strategies.<\/li>\n<\/ul>\n<p><strong>The Study Explore <\/strong><strong>COVID 19 Outbreak Impact Analysis<\/strong><\/p>\n<ul>\n<li>What should be entry strategies, countermeasures to economic impact, and marketing channels?<\/li>\n<li>What are market dynamics?<\/li>\n<li>What are challenges and opportunities?<\/li>\n<li>What is economic impact on market?<\/li>\n<li>What is current market status? What\u2019s market competition in this industry, both company, and country wise? What\u2019s market analysis by taking applications and types in consideration?<\/li>\n<\/ul>\n<p><strong>Inquire more and share questions if any before the purchase on this report at<\/strong><\/p>\n<p><strong><a href=\"https:\/\/reportocean.com\/industry-verticals\/sample-request?report_id=QY4851&amp;cat_title=Healthcare\">https:\/\/reportocean.com\/industry-verticals\/sample-request?report_id=QY4851&amp;cat_title=Healthcare<\/a><\/strong><\/p>\n<p><strong>Key Points Covered in <\/strong><strong>RNA-Based Therapeutics and Vaccines<\/strong> <strong>Market Report:<\/strong><\/p>\n<p>1 Report Overview<\/p>\n<p>1,1 Study Scope<\/p>\n<p>1,2 Key Market Segments<\/p>\n<p>1,3 Players Covered: Ranking by RNA-Based Therapeutics and Vaccines Revenue<\/p>\n<p>1,4 Market by Type<\/p>\n<p>1,4,1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type: 2020 VS 2026<\/p>\n<p>1,4,2 RNA-Based Therapeutics<\/p>\n<p>1,4,3 RNA-Based Vaccines<\/p>\n<p>1,5 Market by Application<\/p>\n<p>1,5,1 Global RNA-Based Therapeutics and Vaccines Market Share by Application: 2020 VS 2026<\/p>\n<p>1,5,2 Oncology<\/p>\n<p>1,5,3 Immunology<\/p>\n<p>1,5,4 Ophthalmology<\/p>\n<p>1,5,5 Cardiovascular Diseases<\/p>\n<p>1,5,6 Infectious Diseases<\/p>\n<p>1,5,7 Genetic Diseases<\/p>\n<p>1,5,8 Others<\/p>\n<p>1,6 Study Objectives<\/p>\n<p>1,7 Years Considered<\/p>\n<p>&nbsp;<\/p>\n<p>2 Global Growth Trends<\/p>\n<p>2,1 Global RNA-Based Therapeutics and Vaccines Market Perspective (2015-2026)<\/p>\n<p>2,2 Global RNA-Based Therapeutics and Vaccines Growth Trends by Regions<\/p>\n<p>2,2,1 RNA-Based Therapeutics and Vaccines Market Size by Regions: 2015 VS 2020 VS 2026<\/p>\n<p>2,2,2 RNA-Based Therapeutics and Vaccines Historic Market Share by Regions (2015-2020)<\/p>\n<p>2,2,3 RNA-Based Therapeutics and Vaccines Forecasted Market Size by Regions (2021-2026)<\/p>\n<p>2,3 Industry Trends and Growth Strategy<\/p>\n<p>2,3,1 Market Top Trends<\/p>\n<p>2,3,2 Market Drivers<\/p>\n<p>2,3,3 Market Challenges<\/p>\n<p>2,3,4 Porter&#8217;s Five Forces Analysis<\/p>\n<p>2,3,5 RNA-Based Therapeutics and Vaccines Market Growth Strategy<\/p>\n<p>2,3,6 Primary Interviews with Key RNA-Based Therapeutics and Vaccines Players (Opinion Leaders)<\/p>\n<p>&nbsp;<\/p>\n<p>3 Competition Landscape by Key Players<\/p>\n<p>3,1 Global Top RNA-Based Therapeutics and Vaccines Players by Market Size<\/p>\n<p>3,1,1 Global Top RNA-Based Therapeutics and Vaccines Players by Revenue (2015-2020)<\/p>\n<p>3,1,2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players (2015-2020)<\/p>\n<p>3,1,3 Global RNA-Based Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)<\/p>\n<p>3,2 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio<\/p>\n<p>3,2,1 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio (CR5 and HHI)<\/p>\n<p>3,2,2 Global Top 10 and Top 5 Companies by RNA-Based Therapeutics and Vaccines Revenue in 2019<\/p>\n<p>3,3 RNA-Based Therapeutics and Vaccines Key Players Head office and Area Served<\/p>\n<p>3,4 Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service<\/p>\n<p>3,5 Date of Enter into RNA-Based Therapeutics and Vaccines Market<\/p>\n<p>3,6 Mergers &amp; Acquisitions, Expansion Plans<\/p>\n<p>&nbsp;<\/p>\n<p>4 Market Size by Type (2015-2026)<\/p>\n<p>4,1 Global RNA-Based Therapeutics and Vaccines Historic Market Size by Type (2015-2020)<\/p>\n<p>4,2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Type (2021-2026)<\/p>\n<p>&nbsp;<\/p>\n<p>5 Market Size by Application (2015-2026)<\/p>\n<p>5,1 Global RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)<\/p>\n<p>5,2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Application (2021-2026)<\/p>\n<p>&nbsp;<\/p>\n<p>6 North America<\/p>\n<p>6,1 North America RNA-Based Therapeutics and Vaccines Market Size (2015-2020)<\/p>\n<p>6,2 RNA-Based Therapeutics and Vaccines Key Players in North America (2019-2020)<\/p>\n<p>6,3 North America RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)<\/p>\n<p>6,4 North America RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)<\/p>\n<p>&nbsp;<\/p>\n<p>7 Europe<\/p>\n<p>7,1 Europe RNA-Based Therapeutics and Vaccines Market Size (2015-2020)<\/p>\n<p>7,2 RNA-Based Therapeutics and Vaccines Key Players in Europe (2019-2020)<\/p>\n<p>7,3 Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)<\/p>\n<p>7,4 Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)<\/p>\n<p>&nbsp;<\/p>\n<p>8 China<\/p>\n<p>8,1 China RNA-Based Therapeutics and Vaccines Market Size (2015-2020)<\/p>\n<p>8,2 RNA-Based Therapeutics and Vaccines Key Players in China (2019-2020)<\/p>\n<p>8,3 China RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)<\/p>\n<p>8,4 China RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)<\/p>\n<p>&nbsp;<\/p>\n<p>9 Japan<\/p>\n<p>9,1 Japan RNA-Based Therapeutics and Vaccines Market Size (2015-2020)<\/p>\n<p>9,2 RNA-Based Therapeutics and Vaccines Key Players in Japan (2019-2020)<\/p>\n<p>9,3 Japan RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)<\/p>\n<p>9,4 Japan RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)<\/p>\n<p>&nbsp;<\/p>\n<p>10 Southeast Asia<\/p>\n<p>10,1 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size (2015-2020)<\/p>\n<p>10,2 RNA-Based Therapeutics and Vaccines Key Players in Southeast Asia (2019-2020)<\/p>\n<p>10,3 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)<\/p>\n<p>10,4 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)<\/p>\n<p>&nbsp;<\/p>\n<p>11 India<\/p>\n<p>11,1 India RNA-Based Therapeutics and Vaccines Market Size (2015-2020)<\/p>\n<p>11,2 RNA-Based Therapeutics and Vaccines Key Players in India (2019-2020)<\/p>\n<p>11,3 India RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)<\/p>\n<p>11,4 India RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)<\/p>\n<p>&nbsp;<\/p>\n<p>12 Central &amp; South America<\/p>\n<p>12,1 Central &amp; South America RNA-Based Therapeutics and Vaccines Market Size (2015-2020)<\/p>\n<p>12,2 RNA-Based Therapeutics and Vaccines Key Players in Central &amp; South America (2019-2020)<\/p>\n<p>12,3 Central &amp; South America RNA-Based Therapeutics and Vaccines Market Size by Type (2015-2020)<\/p>\n<p>12,4 Central &amp; South America RNA-Based Therapeutics and Vaccines Market Size by Application (2015-2020)<\/p>\n<p>&nbsp;<\/p>\n<p>13 Key Players Profiles<\/p>\n<p>13,1 Alnylam Pharmaceuticals<\/p>\n<p>13,1,1 Alnylam Pharmaceuticals Company Details<\/p>\n<p>13,1,2 Alnylam Pharmaceuticals Business Overview<\/p>\n<p>13,1,3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction<\/p>\n<p>13,1,4 Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020))<\/p>\n<p>13,1,5 Alnylam Pharmaceuticals Recent Development<\/p>\n<p>13,2 Arbutus Biopharma<\/p>\n<p>13,2,1 Arbutus Biopharma Company Details<\/p>\n<p>13,2,2 Arbutus Biopharma Business Overview<\/p>\n<p>13,2,3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Introduction<\/p>\n<p>13,2,4 Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)<\/p>\n<p>13,2,5 Arbutus Biopharma Recent Development<\/p>\n<p>13,3 Arrowhead Pharmaceuticals<\/p>\n<p>13,3,1 Arrowhead Pharmaceuticals Company Details<\/p>\n<p>13,3,2 Arrowhead Pharmaceuticals Business Overview<\/p>\n<p>13,3,3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction<\/p>\n<p>13,3,4 Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)<\/p>\n<p>13,3,5 Arrowhead Pharmaceuticals Recent Development<\/p>\n<p>13,4 BioNTech<\/p>\n<p>13,4,1 BioNTech Company Details<\/p>\n<p>13,4,2 BioNTech Business Overview<\/p>\n<p>13,4,3 BioNTech RNA-Based Therapeutics and Vaccines Introduction<\/p>\n<p>13,4,4 BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)<\/p>\n<p>13,4,5 BioNTech Recent Development<\/p>\n<p>13,5 CureVac<\/p>\n<p>13,5,1 CureVac Company Details<\/p>\n<p>13,5,2 CureVac Business Overview<\/p>\n<p>13,5,3 CureVac RNA-Based Therapeutics and Vaccines Introduction<\/p>\n<p>13,5,4 CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)<\/p>\n<p>13,5,5 CureVac Recent Development<\/p>\n<p>13,6 Dicerna Pharmaceuticals<\/p>\n<p>13,6,1 Dicerna Pharmaceuticals Company Details<\/p>\n<p>13,6,2 Dicerna Pharmaceuticals Business Overview<\/p>\n<p>13,6,3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction<\/p>\n<p>13,6,4 Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)<\/p>\n<p>13,6,5 Dicerna Pharmaceuticals Recent Development<\/p>\n<p>13,7 Regulus Therapeutics<\/p>\n<p>13,7,1 Regulus Therapeutics Company Details<\/p>\n<p>13,7,2 Regulus Therapeutics Business Overview<\/p>\n<p>13,7,3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Introduction<\/p>\n<p>13,7,4 Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)<\/p>\n<p>13,7,5 Regulus Therapeutics Recent Development<\/p>\n<p>13,8 Marina Biotech<\/p>\n<p>13,8,1 Marina Biotech Company Details<\/p>\n<p>13,8,2 Marina Biotech Business Overview<\/p>\n<p>13,8,3 Marina Biotech RNA-Based Therapeutics and Vaccines Introduction<\/p>\n<p>13,8,4 Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)<\/p>\n<p>13,8,5 Marina Biotech Recent Development<\/p>\n<p>13,9 MiRagen Therapeutics<\/p>\n<p>13,9,1 MiRagen Therapeutics Company Details<\/p>\n<p>13,9,2 MiRagen Therapeutics Business Overview<\/p>\n<p>13,9,3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Introduction<\/p>\n<p>13,9,4 MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)<\/p>\n<p>13,9,5 MiRagen Therapeutics Recent Development<\/p>\n<p>13,10 Moderna Therapeutics<\/p>\n<p>13,10,1 Moderna Therapeutics Company Details<\/p>\n<p>13,10,2 Moderna Therapeutics Business Overview<\/p>\n<p>13,10,3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Introduction<\/p>\n<p>13,10,4 Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)<\/p>\n<p>13,10,5 Moderna Therapeutics Recent Development<\/p>\n<p>13,11 Quark Pharmaceuticals<\/p>\n<p>10,11,1 Quark Pharmaceuticals Company Details<\/p>\n<p>10,11,2 Quark Pharmaceuticals Business Overview<\/p>\n<p>10,11,3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction<\/p>\n<p>10,11,4 Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)<\/p>\n<p>10,11,5 Quark Pharmaceuticals Recent Development<\/p>\n<p>13,12 Roche<\/p>\n<p>10,12,1 Roche Company Details<\/p>\n<p>10,12,2 Roche Business Overview<\/p>\n<p>10,12,3 Roche RNA-Based Therapeutics and Vaccines Introduction<\/p>\n<p>10,12,4 Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)<\/p>\n<p>10,12,5 Roche Recent Development<\/p>\n<p>13,13 Sylentis<\/p>\n<p>10,13,1 Sylentis Company Details<\/p>\n<p>10,13,2 Sylentis Business Overview<\/p>\n<p>10,13,3 Sylentis RNA-Based Therapeutics and Vaccines Introduction<\/p>\n<p>10,13,4 Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2015-2020)<\/p>\n<p>10,13,5 Sylentis Recent Development<\/p>\n<p>&nbsp;<\/p>\n<p>14 Analyst&#8217;s Viewpoints\/Conclusions<\/p>\n<p>&nbsp;<\/p>\n<p>15 Appendix<\/p>\n<p>15,1 Research Methodology<\/p>\n<p>15,1,1 Methodology\/Research Approach<\/p>\n<p>15,1,2 Data Source<\/p>\n<p>15,2 Disclaimer<\/p>\n<p>15,3 Author Details<\/p>\n<p>\u2026\u2026..and view more in complete table of Contents<\/p>\n<p><strong><em>Browse Premium Research Report with Tables and Figures at @ <a href=\"https:\/\/reportocean.com\/industry-verticals\/sample-request?report_id=QY4851&amp;cat_title=Healthcare\">https:\/\/reportocean.com\/industry-verticals\/sample-request?report_id=QY4851&amp;cat_title=Healthcare<\/a><\/em><\/strong><\/p>\n<p>Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.<\/p>\n<p><strong>About Report Ocean:<\/strong><\/p>\n<p>We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today\u2019s competitive environment. Report Ocean is \u201cone-stop solution\u201d for individuals, organizations, and industries that are looking for innovative market research reports.<\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/rna-based-therapeutics-and-vaccines-market-trend\/\" rel=\"tag\">RNA-Based Therapeutics and Vaccines Market Trend<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/rna-based-therapeutics-and-vaccines-market-analysis\/\" rel=\"tag\">RNA Based Therapeutics And Vaccines Market Analysis<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/rna-based-therapeutics-and-vaccines-market-development\/\" rel=\"tag\">\u00a0RNA Based Therapeutics And Vaccines Market Development<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/rna-based-therapeutics-and-vaccines-market-forecast\/\" rel=\"tag\">\u00a0RNA Based Therapeutics And Vaccines Market Forecast<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/rna-based-therapeutics-and-vaccines-market-growth\/\" rel=\"tag\">\u00a0RNA Based Therapeutics And Vaccines Market Growth<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/rna-based-therapeutics-and-vaccines-market-size\/\" rel=\"tag\">\u00a0RNA Based Therapeutics And Vaccines Market Size<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/rna-based-therapeutics-and-vaccines-market-share\/\" rel=\"tag\">RNA-Based Therapeutics and Vaccines Market Share<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/rna-based-therapeutics-and-vaccines-market\/\" rel=\"tag\">RNA-Based Therapeutics and Vaccines Market<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/rna-based-therapeutics-and-vaccines-market-scope\/\" rel=\"tag\">RNA-Based Therapeutics and Vaccines Market Scope<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/rna-based-therapeutics-and-vaccines-market-sales\/\" rel=\"tag\">RNA-Based Therapeutics and Vaccines Market Sales<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/rna-based-therapeutics-and-vaccines-market-opportunities\/\" rel=\"tag\">RNA-Based Therapeutics and Vaccines Market Opportunities<\/a><\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.reportocean.com\/\" target=\"_blank\">https:\/\/www.reportocean.com\/<\/a><br \/><b>Contact Information:<\/b><br \/>Get in Touch with Us:<\/p>\n<p>Report Ocean<\/p>\n<p>Email: sales@reportocean.com<\/p>\n<p>Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 \u2013 UNITED STATES<\/p>\n<p>Tel: +1 888 212 3539 (US \u2013 TOLL FREE)<\/p>\n<p>Website: https:\/\/www.reportocean.com\/<\/p>\n<p>Blog: https:\/\/reportoceanblog.com\/<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn-internal-distribution\/\" rel=\"category tag\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Get in Touch with Us:<\/p>\n<p>Report Ocean<\/p>\n<p>Email: sales@reportocean.com<\/p>\n<p>Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 \u2013 UNITED STATES<\/p>\n<p>Tel: +1 888 212 3539 (US \u2013 TOLL FREE)<\/p>\n<p>Website: https:\/\/www.reportocean.com\/<\/p>\n<p>Blog: https:\/\/reportoceanblog.com\/<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Global RNA-Based Therapeutics and Vaccines Market Size, Status and Forecast 2020-2026&nbsp; , Covid 19 Outbreak Impact research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market&rsquo;s historic and forecast market &hellip; <a href=\"https:\/\/icrowdnewswire.com\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/\">Continue reading <span>RNA-Based Therapeutics and Vaccines Market Witness Robust Growth | Alnylam Pharmaceuticals,  Arbutus Biopharma,  Arrowhead Pharmaceuticals<\/span><\/a> <a href=\"https:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":88,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,67,57,64,4],"tags":[],"class_list":["post-90425","post","type-post","status-publish","format-standard","hentry","category-english","category-icn-internal-distribution","category-ips","category-reportedtimes","category-research-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>RNA-Based Therapeutics and Vaccines Market Witness Robust Growth | Alnylam Pharmaceuticals, Arbutus Biopharma, Arrowhead Pharmaceuticals - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RNA-Based Therapeutics and Vaccines Market Witness Robust Growth | Alnylam Pharmaceuticals, Arbutus Biopharma, Arrowhead Pharmaceuticals - Business\" \/>\n<meta property=\"og:description\" content=\"Global RNA-Based Therapeutics and Vaccines Market Size, Status and Forecast 2020-2026&nbsp; , Covid 19 Outbreak Impact research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market&rsquo;s historic and forecast market &hellip; Continue reading RNA-Based Therapeutics and Vaccines Market Witness Robust Growth | Alnylam Pharmaceuticals, Arbutus Biopharma, Arrowhead Pharmaceuticals Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-24T14:56:00+00:00\" \/>\n<meta name=\"author\" content=\"aamirbeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"aamirbeg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/\",\"url\":\"http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/\",\"name\":\"RNA-Based Therapeutics and Vaccines Market Witness Robust Growth | Alnylam Pharmaceuticals, Arbutus Biopharma, Arrowhead Pharmaceuticals - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"datePublished\":\"2020-11-24T14:56:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/53740b3884b22d3bab609a0da4dc98e7\"},\"breadcrumb\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RNA-Based Therapeutics and Vaccines Market Witness Robust Growth | Alnylam Pharmaceuticals, Arbutus Biopharma, Arrowhead Pharmaceuticals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/53740b3884b22d3bab609a0da4dc98e7\",\"name\":\"aamirbeg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/61d9c56d3ee1d58adc39e634234541de4f20236e6d84e7a6fb3245c97608410b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/61d9c56d3ee1d58adc39e634234541de4f20236e6d84e7a6fb3245c97608410b?s=96&d=mm&r=g\",\"caption\":\"aamirbeg\"},\"sameAs\":[\"https:\/\/icrowdnewswire.com\/fc\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/aamirbeg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RNA-Based Therapeutics and Vaccines Market Witness Robust Growth | Alnylam Pharmaceuticals, Arbutus Biopharma, Arrowhead Pharmaceuticals - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/","og_locale":"en_US","og_type":"article","og_title":"RNA-Based Therapeutics and Vaccines Market Witness Robust Growth | Alnylam Pharmaceuticals, Arbutus Biopharma, Arrowhead Pharmaceuticals - Business","og_description":"Global RNA-Based Therapeutics and Vaccines Market Size, Status and Forecast 2020-2026&nbsp; , Covid 19 Outbreak Impact research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market&rsquo;s historic and forecast market &hellip; Continue reading RNA-Based Therapeutics and Vaccines Market Witness Robust Growth | Alnylam Pharmaceuticals, Arbutus Biopharma, Arrowhead Pharmaceuticals Continue Reading &rarr;","og_url":"http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/","og_site_name":"Business","article_published_time":"2020-11-24T14:56:00+00:00","author":"aamirbeg","twitter_card":"summary_large_image","twitter_misc":{"Written by":"aamirbeg","Est. reading time":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/","url":"http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/","name":"RNA-Based Therapeutics and Vaccines Market Witness Robust Growth | Alnylam Pharmaceuticals, Arbutus Biopharma, Arrowhead Pharmaceuticals - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"datePublished":"2020-11-24T14:56:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/53740b3884b22d3bab609a0da4dc98e7"},"breadcrumb":{"@id":"http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ipsnews.net\/business\/2020\/11\/24\/rna-based-therapeutics-and-vaccines-market-witness-robust-growth-alnylam-pharmaceuticals-arbutus-biopharma-arrowhead-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"RNA-Based Therapeutics and Vaccines Market Witness Robust Growth | Alnylam Pharmaceuticals, Arbutus Biopharma, Arrowhead Pharmaceuticals"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/53740b3884b22d3bab609a0da4dc98e7","name":"aamirbeg","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/61d9c56d3ee1d58adc39e634234541de4f20236e6d84e7a6fb3245c97608410b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/61d9c56d3ee1d58adc39e634234541de4f20236e6d84e7a6fb3245c97608410b?s=96&d=mm&r=g","caption":"aamirbeg"},"sameAs":["https:\/\/icrowdnewswire.com\/fc"],"url":"https:\/\/ipsnews.net\/business\/author\/aamirbeg\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/90425","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/88"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=90425"}],"version-history":[{"count":4,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/90425\/revisions"}],"predecessor-version":[{"id":90607,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/90425\/revisions\/90607"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=90425"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=90425"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=90425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}